+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell Therapy Biomanufacturing Market - Global Forecast 2026-2032- Product Image
Cell Therapy Biomanufacturing Market - Global Forecast 2026-2032- Product Image
Sale

Cell Therapy Biomanufacturing Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6123307
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cell Therapy Biomanufacturing Market is projected to reach USD 11.27 Billion in 2026. It is expected to continue growing at a CAGR of 17.58%, reaching USD 30.07 Billion by 2032.

Cell Therapy Biomanufacturing: Executive Overview

Cell therapy biomanufacturing encompasses the development, production, testing, storage, and distribution of living-cell-based therapies. The field is moving from largely bespoke laboratory operations toward controlled, reproducible, and scalable manufacturing systems. Progress depends on reliable starting materials, closed processing, validated analytical methods, robust cold-chain logistics, and facilities designed for patient-specific or batch-based production. Regulatory expectations increasingly emphasize product consistency, traceability, contamination control, and evidence that manufacturing processes remain fit for purpose as therapies advance through development.

From Bespoke Production to Platform-Based Manufacturing

The manufacturing landscape is being reshaped by the need to manage biological variability, short product shelf lives, and complex release requirements. Developers are adopting modular facilities, closed or automated processing, standardized raw materials, digital batch records, and process analytical technologies to reduce manual intervention and improve comparability. Parallel advances in allogeneic approaches, induced pluripotent stem-cell platforms, cryopreservation, and decentralized production are broadening operating models, while regulators and manufacturers continue to address chain-of-identity, chain-of-custody, and long-term product monitoring.

Artificial Intelligence Strengthens Process Control and Decision-Making

Artificial intelligence can support cell therapy biomanufacturing by identifying process deviations, integrating multivariable datasets, improving image-based cell characterization, and assisting with predictive maintenance and scheduling. Machine-learning tools may also help optimize media conditions, detect contamination signals, and prioritize investigations. Their value depends on representative training data, validated algorithms, explainable outputs, cybersecurity, and strong data governance. AI should therefore augment-not replace-qualified personnel, established quality systems, and scientifically justified process controls, particularly where decisions affect batch release or patient safety.

Regional Insights Across Established and Emerging Manufacturing Ecosystems

North America benefits from mature advanced-therapy infrastructure, experienced clinical networks, and substantial investment in automation and quality systems. Europe combines sophisticated research capabilities with harmonized regulatory structures, although cross-border logistics and national reimbursement processes can complicate deployment. Asia-Pacific is expanding manufacturing capacity and technical expertise, with Japan, China, South Korea, Australia, and India developing distinct regulatory and industrial pathways. Latin America is strengthening specialist capabilities but continues to face constraints in financing, skilled labor, and cold-chain access. The Middle East is emphasizing translational healthcare infrastructure and strategic localization, while Africa’s progress is concentrated around research institutions, public-health priorities, and selected clinical centers.

Group-Level Priorities Shape Collaboration and Access

ASEAN countries are increasingly focused on regional clinical collaboration, workforce development, and improving consistency in advanced-therapy regulation. BRICS members present diverse manufacturing capabilities and policy environments, creating opportunities for technology transfer while requiring careful alignment of quality standards. The European Union benefits from regulatory coordination and cross-border scientific networks, but implementation remains influenced by national health systems. G7 economies generally contribute advanced research, specialized suppliers, and demanding quality expectations. GCC countries are investing in healthcare modernization and local capability, while NATO members span a broad set of established and emerging biomanufacturing ecosystems whose cooperation can support resilience, training, and supply-chain security.

Country-Level Capabilities Reflect Different Policy and Infrastructure Conditions

The United States and Canada have deep clinical-development, contract manufacturing, and advanced-therapy expertise. The United Kingdom, Germany, France, Italy, and Spain combine strong research institutions with established pharmaceutical quality systems, while navigating differing national adoption and reimbursement pathways. China is expanding domestic biomanufacturing and regulatory capacity; Japan emphasizes precision manufacturing and regenerative-medicine expertise; and South Korea is developing integrated biotechnology infrastructure. Australia supports translational research across geographically dispersed systems. India is building specialized capabilities alongside a large pharmaceutical workforce. Brazil and Mexico are strengthening regional access and clinical infrastructure. Russia retains scientific and industrial assets, though international collaboration and supply access can affect manufacturing development.

Priorities for Leaders Building Reliable Cell Therapy Operations

Industry leaders should design manufacturing platforms around product-specific risk, beginning with robust characterization of starting materials and clear critical quality attributes. They should prioritize closed and automated workflows where justified, qualify multiple critical suppliers, and establish redundant cold-chain and digital traceability controls. Workforce programs should combine cell biology, engineering, quality, data science, and regulatory expertise. Companies should validate analytical methods early, document comparability across process changes, and establish governance for AI-enabled tools before deployment. Partnerships with hospitals, regulators, technology providers, and logistics specialists can accelerate learning while preserving accountability for patient safety and product quality.

Research Methodology for the Executive Summary

This summary uses a qualitative synthesis of established cell therapy biomanufacturing themes, including process development, facility design, automation, analytics, quality management, regulation, workforce requirements, logistics, and regional ecosystem conditions. Geographic coverage was organized across the specified regions, country groupings, and countries to identify recurring operational patterns rather than to rank markets. Conclusions are limited to evidence-based structural developments and practical implications. No market estimates, market shares, forecasts, or company-specific claims are included.

A Quality-First Path Toward Scalable Cell Therapy Manufacturing

Cell therapy biomanufacturing is advancing through the convergence of biology, engineering, digital systems, and regulatory science. Sustainable progress will depend less on isolated technical breakthroughs than on repeatable processes, dependable materials, validated analytics, skilled teams, and resilient distribution. Organizations that build flexibility into facilities and data systems while maintaining rigorous quality oversight will be better positioned to translate promising cell therapies into consistent clinical products across diverse healthcare environments.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.1.1. Transition to Commercial-Stage Manufacturing
4.3.1.2. Rising Quality and CMC Intensity
4.3.1.3. Automation and Closed Processing
4.3.1.4. Therapeutic Breadth and Product Approvals
4.3.2. Key Restraints
4.3.2.1. Program Attrition and Capacity Risk
4.3.2.2. Total Cost and Access Pressure
4.3.2.3. Specialized Workforce Gap
4.3.2.4. Material Variability and Qualification Burden
4.3.3. Key Opportunities
4.3.3.1. Asia-Pacific Manufacturing Localization
4.3.3.2. Integrated Lifecycle Services
4.3.3.3. Digital Quality and Release Enablement
4.3.3.4. Distributed Manufacturing Enablement
4.3.4. Key Challenges
4.3.4.1. Comparability Through Manufacturing Change
4.3.4.2. Network Traceability and Logistics
4.3.4.3. Data Interoperability and Governance
4.3.4.4. Program-Linked Utilization
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Cell Therapy Biomanufacturing Market, by Offering
7.1. Introduction
7.2. Services
7.2.1. Cell Line Development & Manufacturing
7.2.2. Analytical
7.2.3. Compliance & Support
7.2.4. Cell-Banking
7.3. Consumables
7.3.1. Growth Media & Supplements
7.3.1.1. Culture Media
7.3.1.2. Growth Factors & Hormones
7.3.1.3. Anti-clumping Agents & Buffers
7.3.2. Single-Use & Fluid Handling Consumables
7.3.3. Downstream & Purification Consumables
7.3.3.1. Ultrafiltration/Diafiltration (UF/DF) Cassettes
7.3.3.2. Chromatography Resins
7.4. Equipment & Instruments
7.4.1. Bioreactors/Fermenters
7.4.2. Cell Sorters
7.4.3. Centrifuges
7.4.4. Incubators
7.5. Solutions
7.5.1. Control & Automation
7.5.2. Analytics & Cloud Platforms
7.5.3. Electronic Batch Records (EBR)
8. Cell Therapy Biomanufacturing Market, by Donor Relation
8.1. Introduction
8.2. Autologous
8.3. Allogeneic
9. Cell Therapy Biomanufacturing Market, by Cell Source
9.1. Introduction
9.2. Mammalian
9.3. Stem & Progenitor
9.4. Human primary
9.5. Microbial
9.6. Insect
10. Cell Therapy Biomanufacturing Market, by Culture Architecture
10.1. Introduction
10.2. Suspension Culture
10.3. Adherent Culture
11. Cell Therapy Biomanufacturing Market, by Genetic Modification Status
11.1. Introduction
11.2. Non-Genetically Modified Cells
11.3. Genetically Modified Cells
11.3.1. Viral Vector-Mediated Modification
11.3.2. Nonviral Genetic Modification
12. Cell Therapy Biomanufacturing Market, by Application
12.1. Introduction
12.2. Cell Therapy & Regenerative Medicine
12.2.1. Mesenchymal Stem Cells (MSCs)
12.2.2. iPS-derived Cells
12.2.3. Cardiomyocytes
12.2.4. Cell Sheets
12.3. Vaccines & Viral Vectors
12.4. Therapeutic Proteins & Antibodies
13. Cell Therapy Biomanufacturing Market, by Development Stage
13.1. Introduction
13.2. Clinical Manufacturing
13.3. Commercial Manufacturing
13.4. Development & Preclinical Manufacturing
14. Cell Therapy Biomanufacturing Market, by Manufacturing Model
14.1. Introduction
14.2. Internal Manufacturing
14.3. Contract Manufacturing
14.4. Hybrid Manufacturing
15. Cell Therapy Biomanufacturing Market, by Automation Level
15.1. Introduction
15.2. Semi-Automated Manufacturing
15.3. Manual Manufacturing
15.4. Automated Manufacturing
16. Cell Therapy Biomanufacturing Market, by Manufacturing Location
16.1. Introduction
16.2. Centralized Manufacturing
16.3. Distributed Manufacturing
16.4. Point-of-Care Manufacturing
17. Cell Therapy Biomanufacturing Market, by Therapeutic Area
17.1. Introduction
17.2. Oncology
17.3. Hematology
17.4. Immunology
17.5. Neurology
17.6. Infectious diseases
18. Cell Therapy Biomanufacturing Market, by Region
18.1. Introduction
18.2. North America
18.3. Asia-Pacific
18.4. Europe
18.5. Latin America
18.6. Middle East
18.7. Africa
19. Cell Therapy Biomanufacturing Market, by Group
19.1. Introduction
19.2. NATO
19.3. G7
19.4. European Union
19.5. BRICS
19.6. ASEAN
19.7. GCC
20. Cell Therapy Biomanufacturing Market, by Country
20.1. Introduction
20.2. United States
20.3. China
20.4. Germany
20.5. Japan
20.6. France
20.7. South Korea
20.8. United Kingdom
20.9. Canada
20.10. Spain
20.11. Italy
20.12. India
20.13. Australia
20.14. Brazil
20.15. Russia
20.16. Mexico
21. Competitive Landscape
21.1. Market Share Analysis, 2025
21.2. Market Concentration Analysis, 2025
21.2.1. Concentration Ratio (CR)
21.2.2. Herfindahl Hirschman Index (HHI)
21.3. Recent Developments & Impact Analysis, 2025
21.4. Product Portfolio Analysis, 2025
21.5. Benchmarking Analysis, 2025
22. Company Profiles
22.1. Thermo Fisher Scientific Inc.
22.2. Danaher Corporation
22.3. Merck KGaA
22.4. Lonza Group AG
22.5. Sartorius AG
22.6. Catalent, Inc.
22.7. AGC Biologics
22.8. Avantor, Inc.
22.9. Terumo Corporation
22.10. Bio-Techne Corporation
22.11. FUJIFILM Corporation
22.12. BioLife Solutions, Inc.
22.13. Eppendorf SE
22.14. Charles River Laboratories International, Inc.
22.15. Samsung BioLogics Co., Ltd.
22.16. Novartis AG
22.17. Hitachi Ltd.
22.18. Johnson & Johnson Services Inc.
22.19. WuXi AppTec Co., Ltd.
22.20. Getinge AB
22.21. Miltenyi Biotec B.V. & Co. KG
22.22. Bristol Myers Squibb Company
22.23. Corning Incorporated
22.24. Takara Bio Inc.
22.25. Gilead Sciences, Inc.
22.26. Fresenius Kabi AG
22.27. Asahi Kasei Corporation
22.28. Cell Therapies Pty Ltd.
22.29. CRISPR Therapeutics AG
22.30. Minaris Advanced Therapies, LLC
22.31. Shikoku Instrumentation CO.,LTD.
22.32. STEMCELL Technologies Canada Inc.
23. Key Experts
LIST OF FIGURES
FIGURE 1. Global Cell Therapy Biomanufacturing Market, Years Considered for the Study
FIGURE 2. Global Cell Therapy Biomanufacturing Market, Research Design
FIGURE 3. Global Cell Therapy Biomanufacturing Market, Research Framework
FIGURE 4. Global Cell Therapy Biomanufacturing Market, Data Triangulation
FIGURE 5. Global Cell Therapy Biomanufacturing Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Cell Therapy Biomanufacturing Market Size, by Offering, 2025 vs 2032 (%)
FIGURE 7. Global Cell Therapy Biomanufacturing Market Size, by Offering, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Cell Therapy Biomanufacturing Market Size, by Donor Relation, 2025 vs 2032 (%)
FIGURE 9. Global Cell Therapy Biomanufacturing Market Size, by Donor Relation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Cell Therapy Biomanufacturing Market Size, by Cell Source, 2025 vs 2032 (%)
FIGURE 11. Global Cell Therapy Biomanufacturing Market Size, by Cell Source, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Cell Therapy Biomanufacturing Market Size, by Culture Architecture, 2025 vs 2032 (%)
FIGURE 13. Global Cell Therapy Biomanufacturing Market Size, by Culture Architecture, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Cell Therapy Biomanufacturing Market Size, by Genetic Modification Status, 2025 vs 2032 (%)
FIGURE 15. Global Cell Therapy Biomanufacturing Market Size, by Genetic Modification Status, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Cell Therapy Biomanufacturing Market Size, by Application, 2025 vs 2032 (%)
FIGURE 17. Global Cell Therapy Biomanufacturing Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Cell Therapy Biomanufacturing Market Size, by Development Stage, 2025 vs 2032 (%)
FIGURE 19. Global Cell Therapy Biomanufacturing Market Size, by Development Stage, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Cell Therapy Biomanufacturing Market Size, by Manufacturing Model, 2025 vs 2032 (%)
FIGURE 21. Global Cell Therapy Biomanufacturing Market Size, by Manufacturing Model, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Cell Therapy Biomanufacturing Market Size, by Automation Level, 2025 vs 2032 (%)
FIGURE 23. Global Cell Therapy Biomanufacturing Market Size, by Automation Level, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 24. Global Cell Therapy Biomanufacturing Market Size, by Manufacturing Location, 2025 vs 2032 (%)
FIGURE 25. Global Cell Therapy Biomanufacturing Market Size, by Manufacturing Location, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 26. Global Cell Therapy Biomanufacturing Market Size, by Therapeutic Area, 2025 vs 2032 (%)
FIGURE 27. Global Cell Therapy Biomanufacturing Market Size, by Therapeutic Area, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 28. Global Cell Therapy Biomanufacturing Market Size, by Region, 2025 vs 2032 (%)
FIGURE 29. Global Cell Therapy Biomanufacturing Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 30. Global Cell Therapy Biomanufacturing Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 31. Global Cell Therapy Biomanufacturing Market Size, by Country, 2025 vs 2032 (%)
FIGURE 32. Global Cell Therapy Biomanufacturing Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 33. Global Cell Therapy Biomanufacturing Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Cell Therapy Biomanufacturing Market Segmentation & Coverage
TABLE 2. Global Cell Therapy Biomanufacturing Market Size, 2017-2032 (USD Million)
TABLE 3. Global Cell Therapy Biomanufacturing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 4. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Cell Line Development & Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Cell Line Development & Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Cell Line Development & Manufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Analytical Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Analytical Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Analytical Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Compliance & Support Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Compliance & Support Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Compliance & Support Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Cell-Banking Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Cell-Banking Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Cell-Banking Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Growth Media & Supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Growth Media & Supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Growth Media & Supplements Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Culture Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Culture Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Culture Media Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Growth Factors & Hormones Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Growth Factors & Hormones Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Growth Factors & Hormones Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Anti-clumping Agents & Buffers Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Anti-clumping Agents & Buffers Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Anti-clumping Agents & Buffers Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Single-Use & Fluid Handling Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Single-Use & Fluid Handling Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Single-Use & Fluid Handling Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Downstream & Purification Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Downstream & Purification Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Downstream & Purification Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Ultrafiltration/Diafiltration (UF/DF) Cassettes Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Ultrafiltration/Diafiltration (UF/DF) Cassettes Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Ultrafiltration/Diafiltration (UF/DF) Cassettes Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Chromatography Resins Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Chromatography Resins Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Chromatography Resins Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Equipment & Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Equipment & Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Equipment & Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Bioreactors/Fermenters Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Bioreactors/Fermenters Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Bioreactors/Fermenters Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Cell Sorters Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Cell Sorters Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Cell Sorters Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Centrifuges Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Centrifuges Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Centrifuges Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Incubators Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Incubators Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Incubators Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Solutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Solutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Solutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Control & Automation Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Control & Automation Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Control & Automation Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Analytics & Cloud Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Analytics & Cloud Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Analytics & Cloud Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Electronic Batch Records (EBR) Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Electronic Batch Records (EBR) Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Electronic Batch Records (EBR) Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Cell Therapy Biomanufacturing Market Size, by Donor Relation, 2017-2032 (USD Million)
TABLE 74. Global Autologous Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Autologous Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Autologous Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Allogeneic Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Allogeneic Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Allogeneic Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Cell Therapy Biomanufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 81. Global Mammalian Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Mammalian Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Mammalian Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Stem & Progenitor Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Stem & Progenitor Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Stem & Progenitor Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Human primary Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Human primary Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Human primary Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Microbial Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Microbial Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Microbial Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Insect Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Insect Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Insect Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Cell Therapy Biomanufacturing Market Size, by Culture Architecture, 2017-2032 (USD Million)
TABLE 97. Global Suspension Culture Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Suspension Culture Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Suspension Culture Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Adherent Culture Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Adherent Culture Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Adherent Culture Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Cell Therapy Biomanufacturing Market Size, by Genetic Modification Status, 2017-2032 (USD Million)
TABLE 104. Global Non-Genetically Modified Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Non-Genetically Modified Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Non-Genetically Modified Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Genetically Modified Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Genetically Modified Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Genetically Modified Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Viral Vector-Mediated Modification Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Viral Vector-Mediated Modification Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Viral Vector-Mediated Modification Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Nonviral Genetic Modification Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Nonviral Genetic Modification Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Nonviral Genetic Modification Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Cell Therapy Biomanufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 117. Global Cell Therapy & Regenerative Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Global Cell Therapy & Regenerative Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. Global Cell Therapy & Regenerative Medicine Market Size, by Country, 2017-2032 (USD Million)
TABLE 120. Global Mesenchymal Stem Cells (MSCs) Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Global Mesenchymal Stem Cells (MSCs) Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. Global Mesenchymal Stem Cells (MSCs) Market Size, by Country, 2017-2032 (USD Million)
TABLE 123. Global iPS-derived Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global iPS-derived Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global iPS-derived Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global Cardiomyocytes Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Global Cardiomyocytes Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. Global Cardiomyocytes Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. Global Cell Sheets Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Global Cell Sheets Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. Global Cell Sheets Market Size, by Country, 2017-2032 (USD Million)
TABLE 132. Global Vaccines & Viral Vectors Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Global Vaccines & Viral Vectors Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. Global Vaccines & Viral Vectors Market Size, by Country, 2017-2032 (USD Million)
TABLE 135. Global Therapeutic Proteins & Antibodies Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Global Therapeutic Proteins & Antibodies Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. Global Therapeutic Proteins & Antibodies Market Size, by Country, 2017-2032 (USD Million)
TABLE 138. Global Cell Therapy Biomanufacturing Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 139. Global Clinical Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Clinical Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Clinical Manufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Commercial Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Global Commercial Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. Global Commercial Manufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. Global Development & Preclinical Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Global Development & Preclinical Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. Global Development & Preclinical Manufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. Global Cell Therapy Biomanufacturing Market Size, by Manufacturing Model, 2017-2032 (USD Million)
TABLE 149. Global Internal Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Global Internal Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. Global Internal Manufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 152. Global Contract Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Global Contract Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. Global Contract Manufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 155. Global Hybrid Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Global Hybrid Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. Global Hybrid Manufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 158. Global Cell Therapy Biomanufacturing Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 159. Global Semi-Automated Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 160. Global Semi-Automated Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 161. Global Semi-Automated Manufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 162. Global Manual Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 163. Global Manual Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. Global Manual Manufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 165. Global Automated Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 166. Global Automated Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. Global Automated Manufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 168. Global Cell Therapy Biomanufacturing Market Size, by Manufacturing Location, 2017-2032 (USD Million)
TABLE 169. Global Centralized Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 170. Global Centralized Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 171. Global Centralized Manufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 172. Global Distributed Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 173. Global Distributed Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 174. Global Distributed Manufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 175. Global Point-of-Care Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 176. Global Point-of-Care Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 177. Global Point-of-Care Manufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 178. Global Cell Therapy Biomanufacturing Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 179. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 180. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 181. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 182. Global Hematology Market Size, by Region, 2017-2032 (USD Million)
TABLE 183. Global Hematology Market Size, by Group, 2017-2032 (USD Million)
TABLE 184. Global Hematology Market Size, by Country, 2017-2032 (USD Million)
TABLE 185. Global Immunology Market Size, by Region, 2017-2032 (USD Million)
TABLE 186. Global Immunology Market Size, by Group, 2017-2032 (USD Million)
TABLE 187. Global Immunology Market Size, by Country, 2017-2032 (USD Million)
TABLE 188. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 189. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 190. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 191. Global Infectious diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 192. Global Infectious diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 193. Global Infectious diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 194. Global Cell Therapy Biomanufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 195. North America Cell Therapy Biomanufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 196. North America Cell Therapy Biomanufacturing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 197. North America Cell Therapy Biomanufacturing Market Size, by Services, 2017-2032 (USD Million)
TABLE 198. North America Cell Therapy Biomanufacturing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 199. North America Cell Therapy Biomanufacturing Market Size, by Growth Media & Supplements, 2017-2032 (USD Million)
TABLE 200. North America Cell Therapy Biomanufacturing Market Size, by Downstream & Purification Consumables, 2017-2032 (USD Million)
TABLE 201. North America Cell Therapy Biomanufacturing Market Size, by Equipment & Instruments, 2017-2032 (USD Million)
TABLE 202. North America Cell Therapy Biomanufacturing Market Size, by Solutions, 2017-2032 (USD Million)
TABLE 203. North America Cell Therapy Biomanufacturing Market Size, by Donor Relation, 2017-2032 (USD Million)
TABLE 204. North America Cell Therapy Biomanufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 205. North America Cell Therapy Biomanufacturing Market Size, by Culture Architecture, 2017-2032 (USD Million)
TABLE 206. North America Cell Therapy Biomanufacturing Market Size, by Genetic Modification Status, 2017-2032 (USD Million)
TABLE 207. North America Cell Therapy Biomanufacturing Market Size, by Genetically Modified Cells, 2017-2032 (USD Million)
TABLE 208. North America Cell Therapy Biomanufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 209. North America Cell Therapy Biomanufacturing Market Size, by Cell Therapy & Regenerative Medicine, 2017-2032 (USD Million)
TABLE 210. North America Cell Therapy Biomanufacturing Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 211. North America Cell Therapy Biomanufacturing Market Size, by Manufacturing Model, 2017-2032 (USD Million)
TABLE 212. North America Cell Therapy Biomanufacturing Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 213. North America Cell Therapy Biomanufacturing Market Size, by Manufacturing Location, 2017-2032 (USD Million)
TABLE 214. North America Cell Therapy Biomanufacturing Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 215. Asia-Pacific Cell Therapy Biomanufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 216. Asia-Pacific Cell Therapy Biomanufacturing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 217. Asia-Pacific Cell Therapy Biomanufacturing Market Size, by Services, 2017-2032 (USD Million)
TABLE 218. Asia-Pacific Cell Therapy Biomanufacturing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 219. Asia-Pacific Cell Therapy Biomanufacturing Market Size, by Growth Media & Supplements, 2017-2032 (USD Million)
TABLE 220. Asia-Pacific Cell Therapy Biomanufacturing Market Size, by Downstream & Purification Consumables, 2017-2032 (USD Million)
TABLE 221. Asia-Pacific Cell Therapy Biomanufacturing Market Size, by Equipment & Instruments, 2017-2032 (USD Million)
TABLE 222. Asia-Pacific Cell Therapy Biomanufacturing Market Size, by Solutions, 2017-2032 (USD Million)
TABLE 223. Asia-Pacific Cell Therapy Biomanufacturing Market Size, by Donor Relation, 2017-2032 (USD Million)
TABLE 224. Asia-Pacific Cell Therapy Biomanufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 225. Asia-Pacific Cell Therapy Biomanufacturing Market Size, by Culture Architecture, 2017-2032 (USD Million)
TABLE 226. Asia-Pacific Cell Therapy Biomanufacturing Market Size, by Genetic Modification Status, 2017-2032 (USD Million)
TABLE 227. Asia-Pacific Cell Therapy Biomanufacturing Market Size, by Genetically Modified Cells, 2017-2032 (USD Million)
TABLE 228. Asia-Pacific Cell Therapy Biomanufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 229. Asia-Pacific Cell Therapy Biomanufacturing Market Size, by Cell Therapy & Regenerative Medicine, 2017-2032 (USD Million)
TABLE 230. Asia-Pacific Cell Therapy Biomanufacturing Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 231. Asia-Pacific Cell Therapy Biomanufacturing Market Size, by Manufacturing Model, 2017-2032 (USD Million)
TABLE 232. Asia-Pacific Cell Therapy Biomanufacturing Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 233. Asia-Pacific Cell Therapy Biomanufacturing Market Size, by Manufacturing Location, 2017-2032 (USD Million)
TABLE 234. Asia-Pacific Cell Therapy Biomanufacturing Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 235. Europe Cell Therapy Biomanufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 236. Europe Cell Therapy Biomanufacturing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 237. Europe Cell Therapy Biomanufacturing Market Size, by Services, 2017-2032 (USD Million)
TABLE 238. Europe Cell Therapy Biomanufacturing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 239. Europe Cell Therapy Biomanufacturing Market Size, by Growth Media & Supplements, 2017-2032 (USD Million)
TABLE 240. Europe Cell Therapy Biomanufacturing Market Size, by Downstream & Purification Consumables, 2017-2032 (USD Million)
TABLE 241. Europe Cell Therapy Biomanufacturing Market Size, by Equipment & Instruments, 2017-2032 (USD Million)
TABLE 242. Europe Cell Therapy Biomanufacturing Market Size, by Solutions, 2017-2032 (USD Million)
TABLE 243. Europe Cell Therapy Biomanufacturing Market Size, by Donor Relation, 2017-2032 (USD Million)
TABLE 244. Europe Cell Therapy Biomanufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 245. Europe Cell Therapy Biomanufacturing Market Size, by Culture Architecture, 2017-2032 (USD Million)
TABLE 246. Europe Cell Therapy Biomanufacturing Market Size, by Genetic Modification Status, 2017-2032 (USD Million)
TABLE 247. Europe Cell Therapy Biomanufacturing Market Size, by Genetically Modified Cells, 2017-2032 (USD Million)
TABLE 248. Europe Cell Therapy Biomanufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 249. Europe Cell Therapy Biomanufacturing Market Size, by Cell Therapy & Regenerative Medicine, 2017-2032 (USD Million)
TABLE 250. Europe Cell Therapy Biomanufacturing Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 251. Europe Cell Therapy Biomanufacturing Market Size, by Manufacturing Model, 2017-2032 (USD Million)
TABLE 252. Europe Cell Therapy Biomanufacturing Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 253. Europe Cell Therapy Biomanufacturing Market Size, by Manufacturing Location, 2017-2032 (USD Million)
TABLE 254. Europe Cell Therapy Biomanufacturing Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 255. Latin America Cell Therapy Biomanufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 256. Latin America Cell Therapy Biomanufacturing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 257. Latin America Cell Therapy Biomanufacturing Market Size, by Services, 2017-2032 (USD Million)
TABLE 258. Latin America Cell Therapy Biomanufacturing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 259. Latin America Cell Therapy Biomanufacturing Market Size, by Growth Media & Supplements, 2017-2032 (USD Million)
TABLE 260. Latin America Cell Therapy Biomanufacturing Market Size, by Downstream & Purification Consumables, 2017-2032 (USD Million)
TABLE 261. Latin America Cell Therapy Biomanufacturing Market Size, by Equipment & Instruments, 2017-2032 (USD Million)
TABLE 262. Latin America Cell Therapy Biomanufacturing Market Size, by Solutions, 2017-2032 (USD Million)
TABLE 263. Latin America Cell Therapy Biomanufacturing Market Size, by Donor Relation, 2017-2032 (USD Million)
TABLE 264. Latin America Cell Therapy Biomanufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 265. Latin America Cell Therapy Biomanufacturing Market Size, by Culture Architecture, 2017-2032 (USD Million)
TABLE 266. Latin America Cell Therapy Biomanufacturing Market Size, by Genetic Modification Status, 2017-2032 (USD Million)
TABLE 267. Latin America Cell Therapy Biomanufacturing Market Size, by Genetically Modified Cells, 2017-2032 (USD Million)
TABLE 268. Latin America Cell Therapy Biomanufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 269. Latin America Cell Therapy Biomanufacturing Market Size, by Cell Therapy & Regenerative Medicine, 2017-2032 (USD Million)
TABLE 270. Latin America Cell Therapy Biomanufacturing Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 271. Latin America Cell Therapy Biomanufacturing Market Size, by Manufacturing Model, 2017-2032 (USD Million)
TABLE 272. Latin America Cell Therapy Biomanufacturing Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 273. Latin America Cell Therapy Biomanufacturing Market Size, by Manufacturing Location, 2017-2032 (USD Million)
TABLE 274. Latin America Cell Therapy Biomanufacturing Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 275. Middle East Cell Therapy Biomanufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 276. Middle East Cell Therapy Biomanufacturing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 277. Middle East Cell Therapy Biomanufacturing Market Size, by Services, 2017-2032 (USD Million)
TABLE 278. Middle East Cell Therapy Biomanufacturing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 279. Middle East Cell Therapy Biomanufacturing Market Size, by Growth Media & Supplements, 2017-2032 (USD Million)
TABLE 280. Middle East Cell Therapy Biomanufacturing Market Size, by Downstream & Purification Consumables, 2017-2032 (USD Million)
TABLE 281. Middle East Cell Therapy Biomanufacturing Market Size, by Equipment & Instruments, 2017-2032 (USD Million)
TABLE 282. Middle East Cell Therapy Biomanufacturing Market Size, by Solutions, 2017-2032 (USD Million)
TABLE 283. Middle East Cell Therapy Biomanufacturing Market Size, by Donor Relation, 2017-2032 (USD Million)
TABLE 284. Middle East Cell Therapy Biomanufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 285. Middle East Cell Therapy Biomanufacturing Market Size, by Culture Architecture, 2017-2032 (USD Million)
TABLE 286. Middle East Cell Therapy Biomanufacturing Market Size, by Genetic Modification Status, 2017-2032 (USD Million)
TABLE 287. Middle East Cell Therapy Biomanufacturing Market Size, by Genetically Modified Cells, 2017-2032 (USD Million)
TABLE 288. Middle East Cell Therapy Biomanufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 289. Middle East Cell Therapy Biomanufacturing Market Size, by Cell Therapy & Regenerative Medicine, 2017-2032 (USD Million)
TABLE 290. Middle East Cell Therapy Biomanufacturing Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 291. Middle East Cell Therapy Biomanufacturing Market Size, by Manufacturing Model, 2017-2032 (USD Million)
TABLE 292. Middle East Cell Therapy Biomanufacturing Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 293. Middle East Cell Therapy Biomanufacturing Market Size, by Manufacturing Location, 2017-2032 (USD Million)
TABLE 294. Middle East Cell Therapy Biomanufacturing Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 295. Africa Cell Therapy Biomanufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 296. Africa Cell Therapy Biomanufacturing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 297. Africa Cell Therapy Biomanufacturing Market Size, by Services, 2017-2032 (USD Million)
TABLE 298. Africa Cell Therapy Biomanufacturing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 299. Africa Cell Therapy Biomanufacturing Market Size, by Growth Media & Supplements, 2017-2032 (USD Million)
TABLE 300. Africa Cell Therapy Biomanufacturing Market Size, by Downstream & Purification Consumables, 2017-2032 (USD Million)
TABLE 301. Africa Cell Therapy Biomanufacturing Market Size, by Equipment & Instruments, 2017-2032 (USD Million)
TABLE 302. Africa Cell Therapy Biomanufacturing Market Size, by Solutions, 2017-2032 (USD Million)
TABLE 303. Africa Cell Therapy Biomanufacturing Market Size, by Donor Relation, 2017-2032 (USD Million)
TABLE 304. Africa Cell Therapy Biomanufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 305. Africa Cell Therapy Biomanufacturing Market Size, by Culture Architecture, 2017-2032 (USD Million)
TABLE 306. Africa Cell Therapy Biomanufacturing Market Size, by Genetic Modification Status, 2017-2032 (USD Million)
TABLE 307. Africa Cell Therapy Biomanufacturing Market Size, by Genetically Modified Cells, 2017-2032 (USD Million)
TABLE 308. Africa Cell Therapy Biomanufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 309. Africa Cell Therapy Biomanufacturing Market Size, by Cell Therapy & Regenerative Medicine, 2017-2032 (USD Million)
TABLE 310. Africa Cell Therapy Biomanufacturing Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 311. Africa Cell Therapy Biomanufacturing Market Size, by Manufacturing Model, 2017-2032 (USD Million)
TABLE 312. Africa Cell Therapy Biomanufacturing Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 313. Africa Cell Therapy Biomanufacturing Market Size, by Manufacturing Location, 2017-2032 (USD Million)
TABLE 314. Africa Cell Therapy Biomanufacturing Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 315. Global Cell Therapy Biomanufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 316. NATO Cell Therapy Biomanufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 317. NATO Cell Therapy Biomanufacturing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 318. NATO Cell Therapy Biomanufacturing Market Size, by Services, 2017-2032 (USD Million)
TABLE 319. NATO Cell Therapy Biomanufacturing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 320. NATO Cell Therapy Biomanufacturing Market Size, by Growth Media & Supplements, 2017-2032 (USD Million)
TABLE 321. NATO Cell Therapy Biomanufacturing Market Size, by Downstream & Purification Consumables, 2017-2032 (USD Million)
TABLE 322. NATO Cell Therapy Biomanufacturing Market Size, by Equipment & Instruments, 2017-2032 (USD Million)
TABLE 323. NATO Cell Therapy Biomanufacturing Market Size, by Solutions, 2017-2032 (USD Million)
TABLE 324. NATO Cell Therapy Biomanufacturing Market Size, by Donor Relation, 2017-2032 (USD Million)
TABLE 325. NATO Cell Therapy Biomanufacturing Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 326. NATO Cell Therapy Biomanufacturing Market Size, by Culture Architecture, 2017-2032 (USD Million)
TABLE 327. NATO Cell Therapy Biomanufacturing Market Size, by Genetic Modification Status, 2017-2032 (USD Million)
TABLE 328. NATO Cell Therapy Biomanufacturing Market Size, by Genetically Modified Cells, 2017-2032 (USD Million)
TABLE 329. NATO Cell Therapy Biomanufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 330. NATO Cell Therapy Biomanufacturing Market Size, by Cell Therapy & Regenerative Medicine, 2017-2032 (USD Million)
TABLE 331. NATO Cell Therapy Biomanufacturing Market Size, by Development Stage, 2017-2032 (USD Million)
TABLE 332. NATO Cell Therapy Biomanufacturing Market Size, by Manufacturing Model, 2017-2032 (USD Million)
TABLE 333. NATO Cell Therapy Biomanufacturing Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 334. NATO Cell Therapy Biomanufacturing Market Size, by Manufacturing Location, 2017-2032 (USD Million)
TABLE 335. NATO Cell Therapy Biomanufacturing Market Size,

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • Lonza Group AG
  • Sartorius AG
  • Catalent, Inc.
  • AGC Biologics
  • Avantor, Inc.
  • Terumo Corporation
  • Bio-Techne Corporation
  • FUJIFILM Corporation
  • BioLife Solutions, Inc.
  • Eppendorf SE
  • Charles River Laboratories International, Inc.
  • Samsung BioLogics Co., Ltd.
  • Novartis AG
  • Hitachi Ltd.
  • Johnson & Johnson Services Inc.
  • WuXi AppTec Co., Ltd.
  • Getinge AB
  • Miltenyi Biotec B.V. & Co. KG
  • Bristol Myers Squibb Company
  • Corning Incorporated
  • Takara Bio Inc.
  • Gilead Sciences, Inc.
  • Fresenius Kabi AG
  • Asahi Kasei Corporation
  • Cell Therapies Pty Ltd.
  • Cellectis S.A.
  • Celleo Biotech Pty Ltd.
  • Cellipont Bioservices
  • Cellistic
  • Cellular Origins
  • CRISPR Therapeutics AG
  • CTMC
  • Editas Medicine, Inc.
  • ElevateBio
  • ENCell Co., Ltd.
  • Genetix Biotherapeutics Inc.
  • Kincell Bio
  • Limula SA
  • Made Scientific, Inc.
  • Minaris Advanced Therapies, LLC
  • OmniaBio Inc.
  • Oribiotech Ltd.
  • PBS Biotech, Inc.
  • RoosterBio, Inc.
  • Shikoku Instrumentation CO.,LTD.
  • STEMCELL Technologies Canada Inc.

Related Topics

Related Reports

Cell & Gene Therapy Biomanufacturing CDMO Market - Global Forecast 2026-2032 - Product Image

Cell & Gene Therapy Biomanufacturing CDMO Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Digital Biomanufacturing Market - Global Forecast 2026-2032 - Product Image

Digital Biomanufacturing Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
The Global Synthetic Biology & Biomanufacturing Market 2026-2036 - Product Image

The Global Synthetic Biology & Biomanufacturing Market 2026-2036

  • Report
  • 1135 Pages
  • Global
Cell and Gene Therapy Biomanufacturing Market - Strategic Insights and Forecasts (2026-2031) - Product Image

Cell and Gene Therapy Biomanufacturing Market - Strategic Insights and Forecasts (2026-2031)

  • Report
  • 154 Pages
  • Global
From
Biomanufacturing Viral Detection and Quantifications Market - Global Strategic Business Report - Product Image

Biomanufacturing Viral Detection and Quantifications Market - Global Strategic Business Report

  • Report
  • 484 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.